Drug Trial Radar · NCT00380627
Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)
Last checked: Nov 20, 2026Latest source record: Aug 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
337
Actual
Start
Sep 1, 2005
Primary completion
Jan 31, 2006
Study completion Jan 31, 2006
Sponsor
- Lead sponsor
- Organon and CoIndustry
- Sponsor type
- Industry
- First posted
- Sep 26, 2006
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 25 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Allow gynecologists to gain experience with arcoxia for treatment of dysmenorrhea.
Conditions
- Pain
Interventions
MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 DaysDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Perception of menstrual pain, through the analog verbal scale during three days.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.